APA (7th ed.) Citation

MY, H., CC, Y., WJ, H., ZW, L., HY, L., MC, C., . . . PW, S. (2026). Piperlongumine suppresses YAP-ET-1-CXCL2 signaling to modulates aggressiveness of triple-negative breast cancer cells. Translational oncology, 66, 102700. https://doi.org/10.1016/j.tranon.2026.102700

Chicago Style (17th ed.) Citation

MY, Hsieh, et al. "Piperlongumine Suppresses YAP-ET-1-CXCL2 Signaling to Modulates Aggressiveness of Triple-negative Breast Cancer Cells." Translational Oncology 66 (2026): 102700. https://doi.org/10.1016/j.tranon.2026.102700.

MLA (9th ed.) Citation

MY, Hsieh, et al. "Piperlongumine Suppresses YAP-ET-1-CXCL2 Signaling to Modulates Aggressiveness of Triple-negative Breast Cancer Cells." Translational Oncology, vol. 66, 2026, p. 102700, https://doi.org/10.1016/j.tranon.2026.102700.